Pretax income is the income that a company earns before paying income taxes. China Isotope & Radiation's pretax income for the
six
months ended in Dec. 2024 was HK$697 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Dec. 2024 was HK$1,119 Mil.
China Isotope & Radiation's pretax margin was 13.70%.
During the past 10 years, China Isotope & Radiation's highest Pretax Margin was 22.57%. The lowest was 13.80%. And the median was 17.01%.
China Isotope & Radiation Pre-Tax Income Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of China Isotope & Radiation's Pre-Tax Income
For the Medical Devices subindustry, China Isotope & Radiation's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Isotope & Radiation's Pre-Tax Income Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, China Isotope & Radiation's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where China Isotope & Radiation's Pre-Tax Income falls into.
Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$1,119 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Isotope & Radiation (HKSE:01763) Pre-Tax Income Explanation
China Isotope & Radiation's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as
During the past 10 years, China Isotope & Radiation's highest Pretax Margin was 22.57%. The lowest was 13.80%. And the median was 17.01%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Isotope & Radiation Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of China Isotope & Radiation's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
China Isotope & Radiation Corp is a Chinese company. It has five operating segments: Pharmaceuticals; Radioactive source products; Irradiation; Radiation therapy equipment and related services and Other businesses. Its Pharmaceutical segment is the key revenue driver, which manufactures and sells imaging diagnostic and therapeutic radiopharmaceuticals imaging, UBT diagnostic kits, test analyzers, and other products. Its radioactive source products segment involves the sale of medical and industrial radioactive source products and technical services. The company's operations are carried out and a majority of its customers are located in the PRC.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:01763 has been successfully added to your 